In vivo electrophysiological assessment
โ
Lynne E. Rueter; Claude De Montigny; Pierre Blier
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 251 KB
๐ 1 views
Flibanserin (BIMT 17) has been described as a 5-HT 1A agonist with preferential affinity for postsynaptic 5-HT 1A receptors and as a 5-HT 2A antagonist. Indeed, using the forskolin-stimulated cAMP accumulation technique, flibanserin but not the 5-HT 1A agonists buspirone and 8-OH-DPAT had agonistic